. 2012 Jun 15;53(4):588–593. doi: 10.1093/jrr/rrs010

Table 2.

Univariate and multivariate analyses on OS, LRC and DMFS

		OS				LRC			DMFS
Variants		n	Five years	uni	multi	Five years	uni	multi	Five years	uni	multi
Age	<60	72	51.4	0.631	0.121	73.3	0.129	0.076	56.0	0.173	0.033
	≥60	59	53.7	0.631	0.121	89.2	0.129	0.076	64.8	0.173	0.033
Tumor bulk	<55 mm	54	59.8	0.358	0.486	79.5	0.768	0.856	74.4	0.010	0.027
Tumor bulk	≥55 mm	77	47.6	0.358	0.486	80.6	0.768	0.856	50.2	0.010	0.027
OTT	<6 weeks	75	53.1	0.789	0.639	78.5	0.532	0.258	63.5	0.626	0.918
OTT	≥6 weeks	56	50.8	0.789	0.639	82.6	0.532	0.258	56.0	0.626	0.918
Hb before RT	<11.9 mg/dl	62	53.1	0.627	0.934	74.5	0.380	0.599	59.3	0.527	0.988
Hb before RT	≥11.9 mg/dl	69	52.2	0.627	0.934	84.8	0.380	0.599	60.6	0.527	0.988
Concurrent chemotherapy	Yes	89	60.4	0.002	0.001	82.6	0.583	0.322	66.6	0.005	0.002
Concurrent chemotherapy	No	42	33.5	0.002	0.001	68.3	0.583	0.322	44.7	0.005	0.002

OS = overall survival, LRC = loco-regional control, DFMS = distant metastasis free survival, uni = univariate analysis, multi = multivariate analysis, OTT = overall treatment time, Hb = hemoglobin, ns = not significant.